BRIEF

on Drägerwerk AG & Co. KGaA (ETR:DRW8)

Drägerwerk Achieves Record Sales in 2025, Sets Positive Outlook for 2026

Stock price chart of Drägerwerk AG & Co. KGaA (EBR:DRW8) showing fluctuations.

Drägerwerk AG & Co. KGaA reported record net sales for 2025, marking a 5.3% increase, adjusted for currency effects. This growth was slightly higher than the previous forecast. Net sales reached EUR 3,482 million, eclipsing the 2024 figure of EUR 3,370.9 million.

Both the medical and safety divisions contributed to this success. The medical division saw a significant rise of 7.4%, while the safety division grew by 2.5%. The company's EBIT surged to a range of EUR 226 to 236 million, improving the EBIT margin to 6.5-6.8%.

Order intake also increased, with a notable 7.9% growth. In line with the company's dividend policy, Dräger plans to distribute around 30% of net profit to shareholders. For 2026, Dräger forecasts a net sales increase of 1.0-5.0% and an EBIT margin of 5.0-7.5%.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Drägerwerk AG & Co. KGaA news